 Home > Biochemistry News > Biotechnology News > Treating seasonal influenza genetically modified cattle to help produce broad-spectrum antibody therapies

Treating seasonal influenza genetically modified cattle to help produce broad-spectrum antibody therapies

 Last Update: 2022-01-12
 Source: Internet
 Author: User

Tags

1 2 tsp

benzaldehyde ir spectrum

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, SAB Biotherapeutics announced that its polyclonal antibody therapy SAB-176 for the treatment of seasonal influenza has reached its primary endpoint in a Phase 2a clinical trial for the treatment of seasonal influenza

Influenza virus infection is one of the most common infectious diseases, causing 2.

SAB-176 is a fully humanized broad-spectrum neutralizing polyclonal antibody

SAB Biotherapeutics' technology platform uses genetically engineered cattle to produce a large number of fully humanized antibodies.

In this randomized, double-blind, placebo-controlled Phase 2a clinical trial, healthy volunteers received SAB-176 or placebo and were nasally inoculated with H1N1 influenza virus.

In addition, in patients with symptoms, SAB-176 significantly reduced the clinical symptoms of influenza compared with placebo (one-sided p=0.

In this study, SAB-176 showed good safety and tolerability, no serious adverse events related to it were observed, and most of the adverse events were mild or moderate

Reference materials:

[1] SAB Biotherapeutics Announces SAB-176 Met its Primary Endpoint in Phase 2a Challenge Study in Adults Infected with Influenza Virus.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.